Top

Published in:

01-12-2014 | Original Article

Relationship between screening plasma glucose concentrations and cancer- and all-cause mortality: the Jichi Medical School (JMS) cohort study

Authors: Eiichi Kakehi, Kazuhiko Kotani, Shizukiyo Ishikawa, Tadao Gotoh, Kazunori Kayaba, Yosikazu Nakamura, Eiji Kajii

Published in: Journal of Public Health | Issue 6/2014

Abstract

Aim

Whether plasma glucose concentrations at the screening level in the public health care setting can predict mortality remains to be determined in Japanese people. The aim of this study was to investigate the relationships between screening plasma glucose concentrations and cause- and all-cause mortality in a general Japanese cohort.

Subjects and methods

The current study investigated 11,998 community-dwelling participants from 12 Japanese communities who had been registered in the Jichi Medical School Cohort Study (a population-based prospective cohort study) between 1992 and 1995. Mortality was documented as the primary outcome. The relationships between screening plasma glucose concentrations and outcomes were analyzed using Cox proportional hazard models.

Results

In all, 1,050 deaths (men/women = 631/419) were identified during a follow-up period of 10.7 years. Compared with the lowest glucose concentration (<5.22 mmol/L), multivariate-adjusted hazard ratios for the highest glucose concentration (≥6.11 mmol/L) were 1.52 (95 % confidence interval [CI], 1.25–1.85) for all-cause mortality and 1.76 (95 % CI, 1.29–2.41) for cancer-cause mortality in men and 4.65 (95 % CI, 1.69–12.78) for myocardial infarction mortality in women.

Conclusions

The current Japanese population-based cohort study suggests that high screening plasma glucose concentrations can predict cancer- and all-cause mortality, particularly in men.

Abe R, Yamagishi S (2008) AGE-RAGE system and carcinogenesis. Curr Pharm Des 14:940–945PubMedCrossRef

American Diabetes Association (2004) Screening for type 2 diabetes. Diabetes Care 27:S11–S14CrossRef

Borch-Johnsen K, Lauritzen T, Glümer C, Sandbaek A (2003) Screening for Type 2 diabetes: should it be now? Diabet Med 20:175–181PubMedCrossRef

Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM (2012) Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 35:1835–1844PubMedCentralPubMedCrossRef

Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH (2004) Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 27:9–12PubMedCrossRef

Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841PubMedCrossRef

Fisman EZ, Motro M, Tenenbaum A, Boyko V, Mandelzweig L, Behar S (2001) Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J 141:485–490PubMedCrossRef

Fodor JG, Tzerovska R (2004) Coronary heart disease: is gender important? J Mens Health Gend 1:32CrossRef

Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 5:313–324CrossRef

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685PubMedCentralPubMedCrossRef

Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L (2012) Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 35:1252–1257PubMedCentralPubMedCrossRef

Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:134–149

Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef

International Diabetes Federation (2013) Diabetes atlas sixth edition. IDF, Brussels, Belgium

Ishikawa S, Gotoh T, Nago N, Kayaba K (2002) Jichi medical school (JMS) cohort study group. J Epidemiol 12:408–417PubMedCrossRef

Janssen PG, Gorter KJ, Stolk RP, Rutten GE (2007) Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. Fam Pract 24:555–561PubMedCrossRef

Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202PubMedCrossRef

Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, Nakamura K, Saitoh S, Nakamura Y, Hayakawa T, Kita Y, Okayama A, Ueshima H, Research Group NIPPONDATA (2008) Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80. Diabetologia 51:575–582PubMedCrossRef

Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, Soda M, Ioka A, Sobue T, Nishimoto H (2013) An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol 43:492–507PubMedCrossRef

Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R (2002) Stroke prevention: management of modifiable vascular risk factors. J Neurol 249:507–517PubMedCrossRef

Manuel DG, Schultz SE (2004) Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care 27:407–414PubMedCrossRef

Murray CJ, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369:448–457PubMedCrossRef

Nucci LB, Toscano CM, Maia AL, Fonseca CD, Britto MM, Duncan BB, Schmidt MI, Brazilian National Campaign for Diabetes Mellitus Detection Working Group (2004) A nationwide population screening program for diabetes in Brazil. Rev Panam Salud Publica 16:320–327PubMedCrossRef

Pandey A, Forte V, Abdallah M, Alickaj A, Mahmud S, Asad S, McFarlane SI (2011) Diabetes mellitus and the risk of cancer. Minerva Endocrinol 36:187–209PubMed

Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M, Asia Pacific Cohort Studies Collaboration (2004) Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110:2678–2686PubMedCrossRef

Pinkhasov RM, Shteynshlyuger A, Hakimian P, Lindsay GK, Samadi DB, Shabsigh R (2010) Are men shortchanged on health? Perspective on life expectancy, morbidity, and mortality in men and women in the United States. Int J Clin Pract 64:465–474PubMedCrossRef

Port SC, Goodarzi MO, Boyle NG, Jennrich RI (2005) Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J 150:209–214PubMedCrossRef

Saaristo T, Moilanen L, Jokelainen J, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S (2010) Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D). Prim Care Diabetes 4:231–239PubMedCrossRef

Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2003) Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 157:1092–1100PubMedCrossRef

Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I (2013) Evaluation of hypertriglyceridemia using non-fasting health checkup data in a Japanese population. J Atheroscler Thromb 20:661–669PubMedCrossRef

Thomas MC, Hardoon SL, Papacosta AO, Morris RW, Wannamethee SG, Sloggett A, Whincup PH (2009) Evidence of an accelerating increase in prevalence of diagnosed Type 2 diabetes in British men, 1978–2005. Diabet Med 26:766–772PubMedCrossRef

van den Donk M, Sandbaek A, Borch-Johnsen K, Lauritzen T, Simmons RK, Wareham NJ, Griffin SJ, Davies MJ, Khunti K, Rutten GE (2011) Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. Diabet Med 28:1416–1424PubMedCrossRef

Ziemer DC, Kolm P, Foster JK, Weintraub WS, Vaccarino V, Rhee MK, Varughese RM, Tsui CW, Koch DD, Twombly JG, Narayan KM, Phillips LS (2008) Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 23:528–535PubMedCentralPubMedCrossRef

Title: Relationship between screening plasma glucose concentrations and cancer- and all-cause mortality: the Jichi Medical School (JMS) cohort study
Authors: Eiichi Kakehi
Kazuhiko Kotani
Shizukiyo Ishikawa
Tadao Gotoh
Kazunori Kayaba
Yosikazu Nakamura
Eiji Kajii
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: Journal of Public Health / Issue 6/2014
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-014-0643-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Relationship between screening plasma glucose concentrations and cancer- and all-cause mortality: the Jichi Medical School (JMS) cohort study

Abstract

Aim

Subjects and methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aim

Subjects and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2014

Binge drinking and experiences of victimization among adolescents: findings of a nationwide representative study in Germany

Duration of untreated illness and predictors of late treatment initiation in anorexia nervosa

Evaluation of different periodontal treatments modes for patients with type 2 diabetes mellitus

Social inequalities in abdominal obesity in Brazilian women: a nationwide study

Psychological distress in rural Australia: regional variation and the role of family functioning and social support

Erratum to: Reliability and validity of a global question on self-reported chronic morbidity